Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
The therapy of myelofibrosis: targeting pathogenesis.
Ruben A. Mesa
Hematology/Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The therapy of myelofibrosis: targeting pathogenesis.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Primary Myelofibrosis
100%
Etanercept
16%
Thalidomide
16%
Stem Cell Transplantation
13%
Therapeutics
13%
Extramedullary Hematopoiesis
9%
Essential Thrombocythemia
8%
Thrombocytosis
8%
Polycythemia Vera
8%
Cytokines
8%
Hydroxyurea
8%
Imatinib Mesylate
7%
Splenomegaly
7%
Hematopoiesis
7%
Splenectomy
7%
Erythropoietin
6%
Proxy
6%
Hematopoietic Stem Cells
6%
Androgens
6%
Signal Transduction
5%
Poisons
4%
Bone Marrow
4%
Tumor Necrosis Factor-alpha
4%
Radiotherapy
4%
Clinical Trials
4%
Morbidity
3%